Infectious disease
LCMV GP33 33-41 (H2-D(b)) KAVYNFATC
Product number: EP11847_1
€105.00*
Prices excl. VAT plus shipping
costs
Available, delivery time:
1-3 days
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
Purity:
95% HPLC-MS
Caution:
For research use only. Not for use in humans.
Amount in mg
1
Description
KAVYNFATC is a linear peptidic epitope (epitope ID30001) studied as part of Pre-glycoprotein polyprotein GP complex from Lymphocytic choriomeningitis mammarenavirus. This epitope has been studied for immune reactivity, tested in T cell assays, B cell assays and MHC ligand assays. LCMV-derived peptide of KAVYNFATC sequence covering 33-41 and H-2D(b) molecule. It recognizes human CD8 T cells, and can be used in the analysis of individual antigen-specific T cells.
TechData
| Sequence: | KAVYNFATC |
| Gene: | GPC |
| Delivery: | 1-3 days |
| C-Terminus: | OH |
| N-Terminus: | H |
| Amount: | 1 mg |
| Counterion: | TFA |
| Protein: | Pre-glycoprotein polyprotein GP complex |
| Species: | Lymphocytic choriomeningitis virus, LCMV |
| Allele: | H-2Db |
| Application: | Flow Cytometry |
| Indication: | Infectious disease |
| Purity: | 95% HPLC-MS |